Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease.

Date publication

mars 2020

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Bonovas S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32170782

Résumé

Uncertainty exists concerning the risk of infection and cancer associated with biologic therapies in elderly patients with inflammatory bowel disease (IBD).

Référence

Aliment. Pharmacol. Ther.. 2020 Mar 13;: